MedPath
NMPA Approval

Recombinant Human Follitropin for Injection

国药准字S20210052

December 14, 2021

Drug Information

注射用重组人促卵泡激素

安欣保

注射剂

5.5μg(75IU)

生物制品

December 14, 2021

Company Information

Applicant Company

山东省济南市高新区新泺大街317号

Manufacturing Company

山东省济南市历城区董家镇849号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

注射用重组人促卵泡激素 - NMPA 批准文号 | MedPath